SIRT1 and metabolic dysfunction-associated steatotic liver disease: Preliminary studies have demonstrated that hepatocyte-specific SIRT1 deletion impairs PPAR-α signaling and decreases fatty acid β-oxidation, resulting in a worse response to HFD, which has been associated with hepatic inflammation, endoplasmic reticulum stress, and NAFLD in mice [104].